Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study [Yahoo! Finance]
LUDWIG ENTERPRISES (LUDG)
Company Research
Source: Yahoo! Finance
its subsidiary Exousia AI is funding a preclinical study on Glioblastoma (GBM), an incurable brain cancer. The study is being done in the lab of Dr. Kiminobu Sugaya PhD, Head of Neuroscience, Burnett School of Biomedical Sciences, University of Central florida, Orlando, Florida. Dr. Sugaya and his research team are developing a more effective way to treat GBM, an aggressive, incurable form of brain cancer. GBM accounts for 48% of all primary malignant brain tumors and is by far the most aggressive brain cancer with an average lifespan of 12-14 months after diagnosis, if not treated. This devastating brain cancer does not distinguish between people, young or old. Well known individuals who have died of GBM include, Beau Biden, John McCain and Ted Kennedy. New research led by Dr. Sugaya, a stem cell researcher and neuroscientist, found that targeting a drug resistant mechanism in cancer stem cells significantly enhanced the efficacy of traditional cancer therapies - making them four
Show less
Read more
Impact Snapshot
Event Time:
LUDG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUDG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUDG alerts
High impacting LUDWIG ENTERPRISES news events
Weekly update
A roundup of the hottest topics
LUDG
News
- Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer StudyAccesswire
- Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024GlobeNewswire
- Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers [Yahoo! Finance]Yahoo! Finance
- Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain CancersGlobeNewswire
- Ludwig Enterprises mRNA Bladder Cancer Study to be Launched [Yahoo! Finance]Yahoo! Finance
LUDG
Sec Filings
- 4/16/24 - Form 10-K
- 3/29/24 - Form NT
- 2/26/24 - Form 8-K
- LUDG's page on the SEC website